Literature DB >> 15602738

All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes.

Jeonghyun Ahn1, Chul Hyun Joo, Ilsun Seo, Donghou Kim, Yoo Kyum Kim, Heuiran Lee.   

Abstract

Coxsackievirus B3 (CVB3) has been identified as a major causative agent of acute and chronic myocarditis, but the involvement of other CVB serotypes in myocarditis has not been investigated. To dissect the pathological properties of different CVB serotypes toward primary cardiomyocytes, we tested their effects on primary cardiomyocyte cultures from neonatal rats. Morphological abnormalities were examined by both light and fluorescence microscopy after Hoechst 33342 staining, and loss of cell viability was estimated by MTT assay. All six CVB serotypes showed a similar degree of severe toxicity toward primary cardiomyocytes. CVB clinical isolates had cytopathic effects (CPEs) similar to those of their respective CVB reference strains. Within 1-2 days of infection with multiplicities of infection MOI 50, the cells began to experience morphological changes including cell shrinkage, rounding-up, and slight nuclear condensation. The irreversible loss of cell viability was readily observed within 3-5 days following virus infection. These results suggest that all six CVB serotypes induce direct, irreversible toxicity towards cardiomyocytes, which eventually leads to the death of infected cells. These findings indicate that the variations in CVB serotype are not the limiting factor determining the susceptibility of cardiomyocytes to CVB infection.

Entities:  

Mesh:

Year:  2005        PMID: 15602738     DOI: 10.1002/jmv.20269

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Antiviral effects of small interfering RNA simultaneously inducing RNA interference and type 1 interferon in coxsackievirus myocarditis.

Authors:  Jeonghyun Ahn; Ara Ko; Eun Jung Jun; Minah Won; Yoo Kyum Kim; Eun-Seon Ju; Eun Seok Jeon; Heuiran Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period.

Authors:  Ralph Feuer; Chelsea M Ruller; Naili An; Jenna M Tabor-Godwin; Ross E Rhoades; Sonia Maciejewski; Robb R Pagarigan; Christopher T Cornell; Stephen J Crocker; William B Kiosses; Ngan Pham-Mitchell; Iain L Campbell; J Lindsay Whitton
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

Review 3.  Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death.

Authors:  Katharine G Harris; Carolyn B Coyne
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-15       Impact factor: 7.638

4.  Multiplexed High-Throughput Serological Assay for Human Enteroviruses.

Authors:  Niila V V Saarinen; Jussi Lehtonen; Riitta Veijola; Johanna Lempainen; Mikael Knip; Heikki Hyöty; Olli H Laitinen; Vesa P Hytönen
Journal:  Microorganisms       Date:  2020-06-26

5.  Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients.

Authors:  Imed Gaaloul; Samira Riabi; Rafik Harrath; Timothy Hunter; Khaldoun B Hamda; Assia B Ghzala; Sally Huber; Mahjoub Aouni
Journal:  Mol Med Rep       Date:  2014-09-18       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.